Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Lymphoid 1Breast 1

Conditions

Leukemia, Myeloid, Acute 48Leukemia, Lymphocytic, Chronic, B-Cell 27Neoplasms 19Lymphoma, Non-Hodgkin 19Recurrence 17Lymphoma, Mantle-Cell 10Lymphoma, Large B-Cell, Diffuse 10Lymphoma, Follicular 9Multiple Myeloma 8Myelodysplastic Syndromes 6Lymphoma 6Lymphoma, B-Cell, Marginal Zone 5Leukemia, Myelomonocytic, Chronic 4Leukemia 4Hematologic Neoplasms 4Chromosome 17 deletion 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Waldenstrom Macroglobulinemia 2Small Cell Lung Carcinoma 2Prostatic Neoplasms 2Lymphoma, T-Cell 2Lymphoma, B-Cell 2Leukemia, Myeloid 2Leukemia, Biphenotypic, Acute 2Carcinoma, Non-Small-Cell Lung 2Tumor Lysis Syndrome 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Philadelphia Chromosome 1

Interventions

Docetaxel 158Prednisone 131Leuprolide 95bicalutamide 86enzalutamide 83Radiotherapy 80Goserelin 80Abiraterone Acetate 76acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 54Magnetic Resonance Spectroscopy 46Zoledronic Acid 44gallium 68 PSMA-11 37Flutamide 34abiraterone 32Estramustine 32radium Ra 223 dichloride 30apalutamide 27Surveys and Questionnaires 26Gonadotropin-Releasing Hormone 26Androgen Antagonists 25cabazitaxel 24Radiosurgery 24Dutasteride 22sipuleucel-T 21Prednisolone 21Triptorelin Pamoate 20Paclitaxel 20luprolide acetate gel depot 19Radiation 19Exercise 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms × venetoclax × Clear all
NCT03751436 2023-10-16

Enzalutamide With Venetoclax in Treating Patients With Metastatic Castration Resistant Prostate Cancer

Roswell Park Cancer Institute

Phase 1 Completed
10 enrolled
Genitourinary

Prostatic Neoplasms

NCT02391480 2019-11-29

A Study Evaluating the Safety and Pharmacokinetics of ABBV-075 in Subjects With Cancer

AbbVie

Phase 1 Completed
128 enrolled
BreastGenitourinaryLymphoidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms, Prostatic Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡